CHARLESTON, S.C., & MISGAV, Israel--(BUSINESS WIRE)--ApiFix® Ltd. announced today that the company intends to expand its commercial activities next month by opening new scoliosis treatment centers in Italy, France, and the Netherlands. The company’s ApiFix® system, which has now been used to correct scoliosis in over 50 adolescents since the system was approved for marketing in Europe, continues to demonstrate impressive results at one-to-three years of follow-up with 25 of these patients.
“Scoliosis surgery is the most invasive procedure in spine. Now, there is a minimally invasive alternative for many of these children and adolescents,” said Prof. Yizhar Floman, M.D., Director of the Israel Spine Center at Assuta Hospital, Tel Aviv, and past President of the Israel Spine Society. “Scoliosis curve correction at one-to-three years follow-up is substantial for these adolescents. Equally important, patients are pain-free and happy with their new back shape. No implant failure has been observed,” added Dr. Floman, principal investigator for the ApiFix® clinical study.
To meet with Prof. Floman at Eurospine 2015 in Copenhagen, Denmark, Sept. 2-4, or the Scoliosis Research Society Meeting in Minneapolis on Sept. 24–26, contact ApiFix Sales & Marketing Manager Saar Wollach: Mobile: + 972 544 511 51; Email: firstname.lastname@example.org.
ApiFix® is a commercial-stage company that has developed the CE-marked ApiFix® System — a non-fusion minimally invasive treatment alternative for Adolescent Idiopathic Scoliosis (AIS). Scoliosis surgery is the most invasive procedure in spine. The average procedure fuses 10 vertebrae together using 20 screws, resulting in significant and permanent loss of spine mobility.